http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004075887-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b18de3d03555f8f677783893a88208a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d70b6cd33734e8b594ea10e154909b10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2004-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf88e73ee889b3bed204b579933c88f3 |
| publicationDate | 2004-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2004075887-A1 |
| titleOfInvention | Use of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea for the treatment of pancreatic cancer, soft-tissue sarcoma, testicular tumors, lymphoma, thymoma, wilm's tumors, renal carcinoma, melanoma, lung cancer, intracerebral metastasis, tumors in the head and neck region, and mammary carcinoma |
| abstract | The invention relates to the use of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea (henceforth also called HECNU ) for the treatment of pancreatic cancer, soft-tissue sarcoma, testicular tumors, lymphoma, thymoma, Wilm's tumor, renal carcinoma, melanoma, lung cancer, intracerebral metastases, tumors in the head and neck region, and mammary carcinoma. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8053430-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8349823-B2 |
| priorityDate | 2003-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.